- ASSOCIATE PROFESSOR Medicine, Endocrinology, Diabetes and Bone Disease
MD, Univ. Nacional Federica Villareal
Residency, Internal Medicine
Cabrini Medical Center
Bellevue Hospital Center
- Dr. Agustin Busta joined the Mount Sinai Beth Israel Medical Center’s Division of Endocrinology as Associate Director of the Diabetes Program and Director of the Clinical Trials Unit. His area of expertise is diabetes management with intensive insulin therapy.
Dr. Busta previously served as an attending endocrinologist at the Mount Sinai Diabetes Center, as well as a clinical instructor in Endocrinology and Diabetes at Mount Sinai School of Medicine. He is certified by the American Board of Internal Medicine and is a member of the American Diabetes Association, the American Society of Internal Medicine and the American Association of Clinical Endocrinologists.
After receiving his medical degree from Federico Villarreal National University School of Medicine in Lima, Peru, he completed an internship in Internal Medicine at Arzobispo Loayza Hospital in Lima. He followed this with a residency in internal medicine at Cabrini Medical Center and a fellowship in endocrinology and metabolism at New York University Medical Center.
Medal and Recognition Award
The National University “Federico Villarreal”, Lima, Peru
ResearchDr. Busta’s research interests have included evaluating the safety and tolerability of pyridoxamine dihydrochloride in patients with diabetic nephropathy, and the role of thiazolidinediones in the prevention of pancreatic beta-cell function.
Alfonso B, Liao E, Busta A, Poretsky L. Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment. Diabetes/metabolism research and reviews 2009 Jul; 25(5).
Abelev Z, Seth A, Patel R, Goldstein S, Bogun M, Paliou M, Schlosser J, Homel P, Busta A, Seto-Young D, Tranbaugh R, Poretsky L. Continuous insulin infusion is associated with a reduced post-surgical length of stay, but not with the complication rate, in patients with diabetes mellitus undergoing coronary artery bypass graft. Journal of endocrinological investigation 2011 Nov; 34(10).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Busta during 2015 and/or 2016. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
317 E. 17th St
Fierman Hall 7th floor
New York, NY 10003